Everolimus (RAD001) in Metastatic Transitional Cell Carcinoma of the Urothelium
Clinical trial NCT00805129 · COMPLETED
Trial details
- NCT number
- NCT00805129
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-12-05
- Primary completion
- 2021-12-15
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.